DE69714085T2 - Verwendung eines kgf-proteinproduktes und eines glp-2 proteinproduktes für die herstellung eines medikamentes - Google Patents
Verwendung eines kgf-proteinproduktes und eines glp-2 proteinproduktes für die herstellung eines medikamentesInfo
- Publication number
- DE69714085T2 DE69714085T2 DE69714085T DE69714085T DE69714085T2 DE 69714085 T2 DE69714085 T2 DE 69714085T2 DE 69714085 T DE69714085 T DE 69714085T DE 69714085 T DE69714085 T DE 69714085T DE 69714085 T2 DE69714085 T2 DE 69714085T2
- Authority
- DE
- Germany
- Prior art keywords
- product
- protein product
- glp
- production
- kgf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101800000221 Glucagon-like peptide 2 Proteins 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3253396P | 1996-12-06 | 1996-12-06 | |
US6207497P | 1997-10-15 | 1997-10-15 | |
PCT/US1997/022735 WO1998024813A2 (en) | 1996-12-06 | 1997-12-08 | Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69714085D1 DE69714085D1 (de) | 2002-08-22 |
DE69714085T2 true DE69714085T2 (de) | 2002-11-14 |
Family
ID=26708564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69714085T Expired - Lifetime DE69714085T2 (de) | 1996-12-06 | 1997-12-08 | Verwendung eines kgf-proteinproduktes und eines glp-2 proteinproduktes für die herstellung eines medikamentes |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1012186B1 (de) |
JP (1) | JP4091988B2 (de) |
AT (1) | ATE220689T1 (de) |
AU (1) | AU5696298A (de) |
CA (1) | CA2272854C (de) |
DE (1) | DE69714085T2 (de) |
DK (1) | DK1012186T3 (de) |
ES (1) | ES2181054T3 (de) |
PT (1) | PT1012186E (de) |
WO (1) | WO1998024813A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
DE69819488T2 (de) * | 1997-05-16 | 2004-08-26 | 1149336 Ontario Inc., Toronto | Verwendung von glp-2 agonisten zur verbesserung der wirkung des oberen gastrointestinaltraktes |
US6248725B1 (en) | 1999-02-23 | 2001-06-19 | Amgen, Inc. | Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction |
US7186683B2 (en) | 2000-09-18 | 2007-03-06 | Sanos Bioscience A/S | Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
EP1970072A1 (de) | 2000-09-18 | 2008-09-17 | Sanos Bioscience A/S | Verwendung von GLP-2-Peptiden zur Behandlung von Hyperparathyreodismus |
US7371721B2 (en) | 2000-09-18 | 2008-05-13 | Sanos Bioscience A/S | Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes |
US7112567B2 (en) | 2001-02-16 | 2006-09-26 | Conjuchem Inc. | Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
MXPA04001526A (es) | 2001-08-21 | 2004-05-31 | Chiron Corp | Composiciones de polipetidos kgf. |
AU2007214362B2 (en) * | 2001-08-21 | 2009-11-26 | Novartis Vaccines And Diagnostics, Inc. | KGF polypeptide compositions |
PT1827483E (pt) * | 2004-12-15 | 2014-09-25 | Swedish Orphan Biovitrum Ab Publ | Formulações terapêuticas do fator de crescimento de queratinócitos |
KR20160083884A (ko) | 2013-11-01 | 2016-07-12 | 스페리움 바이오메드 에스.엘. | 치료제 및 미용제의 경피 전달을 위한 봉입체 |
ES2909074T3 (es) * | 2016-05-06 | 2022-05-05 | Phasebio Pharmaceuticals Inc | Proteínas de fusión ELP para liberación controlada y sostenida |
-
1997
- 1997-12-08 DE DE69714085T patent/DE69714085T2/de not_active Expired - Lifetime
- 1997-12-08 CA CA002272854A patent/CA2272854C/en not_active Expired - Fee Related
- 1997-12-08 WO PCT/US1997/022735 patent/WO1998024813A2/en active IP Right Grant
- 1997-12-08 JP JP52589498A patent/JP4091988B2/ja not_active Expired - Fee Related
- 1997-12-08 EP EP97953157A patent/EP1012186B1/de not_active Expired - Lifetime
- 1997-12-08 AT AT97953157T patent/ATE220689T1/de active
- 1997-12-08 ES ES97953157T patent/ES2181054T3/es not_active Expired - Lifetime
- 1997-12-08 DK DK97953157T patent/DK1012186T3/da active
- 1997-12-08 PT PT97953157T patent/PT1012186E/pt unknown
- 1997-12-08 AU AU56962/98A patent/AU5696298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69714085D1 (de) | 2002-08-22 |
JP4091988B2 (ja) | 2008-05-28 |
ES2181054T3 (es) | 2003-02-16 |
EP1012186B1 (de) | 2002-07-17 |
ATE220689T1 (de) | 2002-08-15 |
CA2272854C (en) | 2004-02-10 |
DK1012186T3 (da) | 2002-11-04 |
WO1998024813A3 (en) | 1998-08-06 |
JP2001510333A (ja) | 2001-07-31 |
CA2272854A1 (en) | 1998-06-11 |
EP1012186A2 (de) | 2000-06-28 |
AU5696298A (en) | 1998-06-29 |
PT1012186E (pt) | 2002-12-31 |
WO1998024813A2 (en) | 1998-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69703508T2 (de) | Verfahren zur Herstellung von sterilen Packungen für Nahtmaterial | |
DE69811114T2 (de) | Tampon für die frauenhygiene oder medizinische zwecke und verfahren zur herstellung desselben | |
DE69714085T2 (de) | Verwendung eines kgf-proteinproduktes und eines glp-2 proteinproduktes für die herstellung eines medikamentes | |
ATE233236T1 (de) | Zwischenprodukte für die herstellung von oximäthern | |
DE69724697D1 (de) | Verfahren zur Aufnahme von Abdrücken, insbesondere zur Herstellung von orthopädischen Schuhen und entsprechendem Material | |
DE69502328T2 (de) | Kryogenisches Rektifikationsverfahren zur Herstellung von Hochdruckstickstoff | |
DE69533433D1 (de) | Verfahren und Mischung zur Herstellung von Polymerprodukten für die Zahnmedizin | |
ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
ES2196082T3 (es) | Analagos del factor de crecimiento de queratinocitos. | |
DE69230717T2 (de) | Verfahren zur Herstellung von 2-Acetyl-1-Pyrrolin in verkapselter Form, Zwischenprodukte und Endprodukt | |
DE69624268D1 (de) | Anlage zur herstellung von polstermaterial | |
DE60112136D1 (de) | Verfahren zur Herstellung von 1-(2,5-Diaminophenyl)ethanol und dessen Verwendung für oxidative Färbeprozesse | |
DE69207386T2 (de) | Verfahren zur Herstellung hochintegrierter kontaktloser EPROM's | |
DE69530705D1 (de) | Selenium-konjugate für die herstellung von freien radikalen enthaltende arzneimittel | |
DE69331479T2 (de) | Polyethylenglycol-Hirudin-Konjugate, deren Verfahren zur Herstellung und Verwendung für die Heilung von Thrombosen | |
ATE295175T1 (de) | Verwendung von unverseifbaren pflanzlichen ölen für die herstellung pharmazeutischer präparate | |
DE3782430T2 (de) | Verwendung eines trypsininhibitors des kunitztyps aus sojabohnen und seiner derivate zur herstellung von medikamenten und denselben enthaltendes agens. | |
DE59606567D1 (de) | Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren | |
DE69609171T8 (de) | Vorrichtung und gerät für die herstellung von vliesen | |
DE69502571T2 (de) | Prozess für die Herstellung von fermentierbarem Material | |
DE69320988T2 (de) | Folge-werkzeug für eine presse zur herstellung von metalldichtungen | |
DE69609882D1 (de) | Verfahren zur Herstellung von normalen und überbasischen Phenolaten | |
ATE191219T1 (de) | Zwischenprodukte und ihre anwendung für die herstellung von n,n'-überbrückten bisindolylmaleimiden | |
DE69820078D1 (de) | Druckfosgenierung von alkoholen zur herstellung von chloroformiaten | |
DE59607664D1 (de) | Verfahren zur Herstellung von 2,4,4,7-Tetramethyl-oct-6-en-3-on und dessen Verwendung als Riechstoff |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: BIOVITRUM AB (PUBL), STOCKHOLM, SE |